ArticleNeuro-oncology2024

Indoximod-based chemo-immunotherapy for pediatric brain tumors: A first-in-children phase I trial.

Theodore S Johnson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.